This is consistent with several independent reports that genetic deletion of IRAK-M renders enhanced anti-tumor immune environment in reducing tumorigenesis ranging from lung cancer to colon cancer (Kesselring et al, 2016; Standiford et al, 2011). This evidence concerns the gene IRAK3 and lung carcinoma.